Biotech stocks, which were sold off yesterday, rebounded this morning. BeiGene (06160) is up 2.48%, trading at HK$214.6; Hansoh Pharmaceutical (03692) rises 2.22% to HK$31.26; China Biologic Products (01177) gains 1.16% to HK$5.225; WuXi AppTec (02359) climbs 1.19% to HK$204.4; CSPC Pharmaceutical Group (01093) increases 0.91% to HK$8.89.

　　The 2026 European Society for Medical Oncology (ESMO Congress) will be held from October 23 to October 27 in Madrid, Spain, with an online platform available. Key highlights and focal studies at this year's congress will cover multiple innovative antibody-drug conjugates (ADCs) and targeted therapies.

　　Currently, the Hang Seng Index stands at 24,105, down 208 points or 0.86%, with main board turnover of HK$25.477 billion. The Hang Seng China Enterprises Index is at 8,112, down 70 points or 0.87%. The Hang Seng Tech Index is at 4,096, down 78 points or 1.87%.
 

Performance of related stocks in the same sector

Stock (Code)	Current Price (HK$)	Change (%)
BeiGene (06160)	214.6	Up 2.48%
Hansoh Pharmaceutical (03692)	31.26	Up 2.22%
China Biologic Products (01177)	5.225	Up 1.16%
WuXi AppTec (02359)	204.4	Up 1.19%
CSPC Pharmaceutical Group (01093)	8.89	Up 0.91%
Innovent Biologics (01801)	88.7	Up 0.68%
Zai Lab (09688)	17.9	Up 2.4%
Colbert Bio (06990)	445.2	Up 1.83%
China Biologic Products (01177)	5.225	Up 1.16%
Derex-B (02526)	220.4	Up 1.1%
Run Yao (03320)	4.655	Up 0.76%
Concord Medical (00867)	10.42	Up 0.39%
Simcere Pharmaceutical (02096)	10.91	Up 0.28%